These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

473 related articles for article (PubMed ID: 28511884)

  • 21. Preoperative nutritional status is an important predictor of survival in patients undergoing surgery for renal cell carcinoma.
    Morgan TM; Tang D; Stratton KL; Barocas DA; Anderson CB; Gregg JR; Chang SS; Cookson MS; Herrell SD; Smith JA; Clark PE
    Eur Urol; 2011 Jun; 59(6):923-8. PubMed ID: 21295907
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Treatment trends, determinants, and survival of partial and radical nephrectomy for stage I renal cell carcinoma: results from the National Cancer Data Base, 2004-2013.
    Plante K; Stewart TM; Wang D; Bratslavsky G; Formica M
    Int Urol Nephrol; 2017 Aug; 49(8):1375-1381. PubMed ID: 28550475
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Appropriateness and Outcomes of Percutaneous Coronary Intervention at Top-Ranked and Nonranked Hospitals inĀ the United States.
    Sukul D; Bhatt DL; Seth M; Zakroysky P; Wojdyla D; Rumsfeld JS; Wang T; Rao SV; Gurm HS
    JACC Cardiovasc Interv; 2018 Feb; 11(4):342-350. PubMed ID: 29471947
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Indication for Lower Extremity Revascularization and Hospital Profiling of Readmissions.
    Gonzalez AA; Cruz CG; Dev S; Osborne NH
    Ann Vasc Surg; 2016 Aug; 35():130-7. PubMed ID: 27311949
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Quality Indicators of End-of-Life Care in Patients With Cancer: What Rate Is Right?
    Barbera L; Seow H; Sutradhar R; Chu A; Burge F; Fassbender K; McGrail K; Lawson B; Liu Y; Pataky R; Potapov A
    J Oncol Pract; 2015 May; 11(3):e279-87. PubMed ID: 25922219
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Perioperative Allogenic Blood Transfusion in Renal Cell Carcinoma: Risk Factors and Effect on Long-term Outcomes.
    Soria F; de Martino M; Leitner CV; Moschini M; Shariat SF; Klatte T
    Clin Genitourin Cancer; 2017 Jun; 15(3):e421-e427. PubMed ID: 28089722
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prognostic implications of sarcomatoid and rhabdoid differentiation in patients with grade 4 renal cell carcinoma.
    Kara O; Maurice MJ; Zargar H; Malkoc E; Akca O; Andrade HS; Ramirez D; Caputo PA; Nelson RJ; Rini B; Kaouk JH
    Int Urol Nephrol; 2016 Aug; 48(8):1253-1260. PubMed ID: 27215555
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The outcome of patients treated with sunitinib prior to planned nephrectomy in metastatic clear cell renal cancer.
    Powles T; Blank C; Chowdhury S; Horenblas S; Peters J; Shamash J; Sarwar N; Boleti E; Sahdev A; O'Brien T; Berney D; Beltran L; Nathan P; Haanen J; Bex A
    Eur Urol; 2011 Sep; 60(3):448-54. PubMed ID: 21612860
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hospital Readmission as a Poor Measure of Quality in Ovarian Cancer Surgery.
    Uppal S; Spencer RJ; Rice LW; Del Carmen MG; Reynolds RK; Griggs JJ
    Obstet Gynecol; 2018 Jul; 132(1):126-136. PubMed ID: 29889756
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Feasibility of Report Cards for Measuring Anesthesiologist Quality for Cardiac Surgery.
    Glance LG; Hannan EL; Fleisher LA; Eaton MP; Dutton RP; Lustik SJ; Li Y; Dick AW
    Anesth Analg; 2016 May; 122(5):1603-13. PubMed ID: 27101502
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Oncologic outcomes of patients with positive surgical margin after partial nephrectomy: a 25-year single institution experience.
    Petros FG; Metcalfe MJ; Yu KJ; Keskin SK; Fellman BM; Chang CM; Gu C; Tamboli P; Matin SF; Karam JA; Wood CG
    World J Urol; 2018 Jul; 36(7):1093-1101. PubMed ID: 29488096
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pre-existing type-2 diabetes is not an adverse prognostic factor in patients with renal cell carcinoma: a single-center retrospective study.
    Antonelli A; Arrighi N; Corti S; Zanotelli T; Cozzoli A; Cosciani Cunico S; Simeone C
    Urol Oncol; 2013 Oct; 31(7):1310-5. PubMed ID: 22281433
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Radical cystectomy in the elderly: national trends and disparities in perioperative outcomes and quality of care.
    Roghmann F; Sukumar S; Ravi P; Trinh VQ; Meskawi M; Ghani KR; Sammon JD; Friedman AA; Peabody JO; Menon M; Noldus J; Karakiewicz PI; Sun M; Trinh QD
    Urol Int; 2014; 92(1):27-34. PubMed ID: 24052104
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Empirically derived composite measures of surgical performance.
    Staiger DO; Dimick JB; Baser O; Fan Z; Birkmeyer JD
    Med Care; 2009 Feb; 47(2):226-33. PubMed ID: 19169124
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Quality of communication about medicines in United States hospitals: A national retrospective study.
    Mullings L; Sankaranarayanan J
    Res Social Adm Pharm; 2017; 13(4):849-856. PubMed ID: 27913084
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Association of Comorbidity, Age, and Radical Surgical Therapy for Prostate Cancer, Bladder Cancer, and Renal Cell Carcinoma.
    Adejoro O; Alishahi A; Konety B
    Urology; 2016 Nov; 97():130-137.e1. PubMed ID: 27397095
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Toward greater adoption of minimally invasive and nephron-sparing surgical techniques for renal cell cancer in the United States.
    Banegas MP; Harlan LC; Mann B; Yabroff KR
    Urol Oncol; 2016 Oct; 34(10):433.e9-433.e17. PubMed ID: 27321355
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Survival after partial and radical nephrectomy for the treatment of stage T1bN0M0 renal cell carcinoma (RCC) in the USA: a propensity scoring approach.
    Badalato GM; Kates M; Wisnivesky JP; Choudhury AR; McKiernan JM
    BJU Int; 2012 May; 109(10):1457-62. PubMed ID: 21933334
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Laparoscopic radical nephrectomy vs laparoscopic or open partial nephrectomy for T1 renal cell carcinoma: comparison of complication rates in elderly patients during the initial phase of adoption.
    Becker A; Ravi P; Roghmann F; Trinh QD; Tian Z; Larouche A; Kim S; Shariat SF; Kluth L; Dahlem R; Fisch M; Graefen M; Eichelberg C; Karakiewicz PI; Sun M
    Urology; 2014 Jun; 83(6):1285-91. PubMed ID: 24862392
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Chromophobe renal cell carcinoma (RCC): oncological outcomes and prognostic factors in a large multicentre series.
    Volpe A; Novara G; Antonelli A; Bertini R; Billia M; Carmignani G; Cunico SC; Longo N; Martignoni G; Minervini A; Mirone V; Simonato A; Terrone C; Zattoni F; Ficarra V; ;
    BJU Int; 2012 Jul; 110(1):76-83. PubMed ID: 22044519
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 24.